Investigating COVID-19 Vaccine Hesitancy Among People Living with HIV in British Columbia, Canada


Last year, researchers at the University of British Columbia conducted a pilot study to determine the possible reasons for vaccine hesitancy among folks attending the AIDS Vancouver grocery program. Researchers now want to elaborate on this study and assess the level of hesitancy and its association with vaccine uptake among folks with HIV provincially. They have obtained ethical approval from the UBC-Behavioural Research Ethics Board.

You are invited to participate in this research study about the factors determining COVID-19 vaccine hesitancy among British Columbia residents living with HIV.  Researchers are evaluating health behaviours towards COVID-19 vaccines in Canada, including AstraZeneca, Janssen, Medicago, Moderna, Pfizer-BioNTech and others.

For this study, COVID-19 vaccine hesitancy is defined as the delay in acceptance or refusal of vaccines despite their availability. Anne Ejiegbu is conducting this study as a graduate student in the MSc Craniofacial Sciences program at the Faculty of Dentistry, University of British Columbia and supervised by Dr. Mario Brondani, an associate professor at the Faculty of Dentistry at the University of British Columbia (UBC). Surveys will be disseminated to members of HIV Organizations in British Columbia via the Qualtrics® platform.

In order to participate in this study, please complete the survey by following this link. Your participation is entirely voluntary and you may withdraw from the study at any point before submitting the survey. However, your answers cannot be withdrawn after submission of the completed survey due to data anonymity. The survey will take approximately 10 minutes to complete. Your response will be collected anonymously, and your email and IP address will not be linked to your response. UBC collects the information in the survey under the authority of sections 26(c) and 26(e) of the BC Freedom of Information and Protection of Privacy Act (BC FIPPA). There are no anticipated risks to you while participating in this research. Still, the study may provoke your thoughts about the Covid-19 vaccines.

Click here for more information and survey access.